{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-027969","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2025-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.692784+00:00","generated_at":"2026-05-16T13:02:56.616997+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Akari shareholders approve share sub-division, warrant exercise, and new articles","bullets":["Approved exercisability of warrants issued in October 2025 offering under Nasdaq Listing Rule 5635(d).","Approved sub-division and re-designation of ordinary shares into 1 ordinary share (0.000000005 GBP) and 19,999 deferred shares.","Authorised directors to allot shares up to nominal amount of USD 3,000, expiring June 30, 2030.","Approved a share buyback contract for all deferred shares and adoption of new articles of association.","Special resolution passed to allot equity securities for cash without pre-emption rights, effective for five years."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-027969","json":"https://secwatch.observer/filing/0001493152-25-027969.json","markdown":"https://secwatch.observer/filing/0001493152-25-027969.md","text":"https://secwatch.observer/filing/0001493152-25-027969.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225027969/0001493152-25-027969-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225027969/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:02:56.616997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}